EndaCof-AC and Hyaluronidase and rituximab
Determining the interaction of EndaCof-AC and Hyaluronidase and rituximab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / codeine
Brand name: EndaCof-AC, Nalex AC
Synonyms: n.a.
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- EndaCof-AC-Hyaluronidase and trastuzumab
- EndaCof-AC-Hyaluronidase injection
- EndaCof-AC-Hyaluronidase Injection (Human)
- EndaCof-AC-Hyaluronidase Subcutaneous, Injection
- EndaCof-AC-Hyate:C
- EndaCof-AC-Hybrisil
- Hyaluronidase and rituximab-EndaCof-C
- Hyaluronidase and rituximab-EndaCof-DM
- Hyaluronidase and rituximab-EndaCof-PD
- Hyaluronidase and rituximab-Endal CD Syrup
- Hyaluronidase and rituximab-Endocet
- Hyaluronidase and rituximab-Endocet 10/325